| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
2.7 -0.3 (-0.1%) |
05-17 16:00 |
|
Open: |
2.88 |
Pre close: |
3 |
Target:
|
4.07 
|
|
High: |
2.95 |
Low: |
2.69 |
Resistance:
|
3.48
3.97
|
|
Volume: |
20,845 |
Market Cap: |
32M |
Support:
|
2.69
2.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.97
|
MACD |
MACD(12,26):
|
-0.18 |
|
MA(20): |
3.24 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
3.53 |
Stochastic Oscillator |
%K(14,3):
|
15.08 |
|
MA(250): |
0.00 |
%D(3): |
22.50 |
|
Average Volume(K) |
3-Month: |
4929
|
52-Week |
High:
|
13.77 |
|
10-Days: |
2946 |
Low: |
2.46 |
|
RSI |
RSI(14):
|
26.53 |
Change(%): |
-66.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-64.5 |
Shares Out. (M) |
11.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-57.2 |
Shares Float (M) |
11.96 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.70 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.280 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.70 |
P/S |
538200000.00 |
|
Operating Margin |
-1280.20 |
Levered Free Cash Flow
(M) |
-4.14 |
P/CF |
-5.66 |
|
|
|
|
|
|
